Professor O.P. Katare Appointed as DPIIT IPR Chair Professor at Panjab University

In a significant development for intellectual property research and policy advocacy, Professor O.P. Katare (Retired), has been appointed as the Chair Professor under the IPR Chair scheme at Panjab University.

The appointment order was formally issued by Panjab University Vice Chancellor, Professor Renu Vig, on Friday late evening, marking a new chapter in the university’s commitment to strengthening intellectual property (IP) education, innovation, and policy development.

A Stalwart in Pharmaceutical Sciences

Professor Katare, who previously served with distinction at UIPS, Panjab University, is widely recognized for his pioneering work in drug delivery systems, pharmaceutical formulation development, and translational research. With an illustrious academic and research career spanning over four decades, he has contributed extensively to both scientific literature and capacity-building in the Indian pharmaceutical landscape.

Prof. Katare has authored numerous peer-reviewed publications and holds several patents in drug formulation and delivery. His work has not only elevated the stature of Panjab University but has also impacted drug development practices at a national level.

DPIIT IPR Chair: A Strategic Initiative

The DPIIT IPR Chair scheme is a Government of India initiative designed to promote research, training, and awareness in the field of intellectual property rights (IPR). Under this scheme, eminent scholars are appointed to lead academic and outreach efforts aimed at strengthening India’s IPR ecosystem.

As the newly appointed IPR Chair Professor, Prof. Katare will be tasked with conducting interdisciplinary research on IPR issues, organizing training programs and workshops for stakeholders, and advising on policy matters related to patents, trademarks, copyrights, and industrial designs.

“Prof. Katare’s appointment under the DPIIT IPR Chair scheme is a matter of immense pride for Panjab University,” said Vice Chancellor Prof. Renu Vig. “His vast experience and deep understanding of innovation in the pharmaceutical sector will provide valuable insights into the evolving intellectual property landscape of India.”

Enhancing IPR Education and Policy

Prof. Katare’s role is expected to enhance the university’s academic offerings in the field of IPR and foster a culture of innovation-driven research. He is also likely to spearhead collaborations with industries, startups, legal experts, and policymakers to help translate academic research into real-world applications protected by robust IP frameworks.

Speaking on his appointment, Prof. Katare expressed gratitude and a renewed sense of purpose. “I am honored to take on this responsibility at a time when India is striving to become a global leader in innovation and IP management. I look forward to contributing to policy formulation, capacity-building, and promoting IP literacy across academic and industrial sectors.”

A Boost for Panjab University’s National Standing

Panjab University has been among the few institutions selected for the DPIIT IPR Chair, reflecting its growing prominence in the national innovation and legal ecosystem. The appointment of an accomplished academic like Prof. Katare is expected to further consolidate the university’s reputation as a hub of IP excellence.

The university administration has indicated that under Prof. Katare’s leadership, new initiatives will be launched to encourage patent filings by faculty and students, host national-level conferences on IP policy, and work closely with DPIIT to align academic efforts with national IPR goals.

Conclusion

Prof. O.P. Katare’s appointment as the DPIIT IPR Chair Professor at Panjab University is not only a recognition of his stellar academic career but also a strategic move to strengthen India’s IPR landscape through informed research and outreach. As he steps into this influential role, expectations are high for new milestones in intellectual property awareness, innovation policy, and academic-industry collaboration.

Panjab University Researchers Develop Eco-Friendly Nanomicelle Platform; File Indian and International Patent Applications

In a significant stride toward sustainable pharmaceutical innovation, researchers from Panjab University have developed a pioneering green nanomicelle platform that promises to revolutionize drug delivery systems. The invention, which is both solvent-free and environmentally friendly, has led the university to file patent applications in India and internationally, highlighting the platform’s global potential and scientific merit.

The innovation is the result of dedicated research led by Professor Indu Pal Kaur from the University Institute of Pharmaceutical Sciences, along with her PhD scholars Bakr Ahmed and Simrandeep Kaur. Together, the team has designed a scalable nanomicelle-based system that addresses critical challenges in the pharmaceutical industry, including eco-sustainability, biocompatibility, and cost-effectiveness.

Nanomicelles are tiny, spherical structures formed by the self-assembly of amphiphilic molecules, widely used for enhancing the solubility and targeted delivery of poorly water-soluble drugs. However, traditional methods of creating these nanocarriers often rely on toxic organic solvents and energy-intensive processes, raising concerns about environmental impact and safety.

What sets this new platform apart is its green synthesis approach — completely free from harmful solvents, making it safer for both patients and the environment. The process is not only non-toxic but also easily reproducible on a large scale, offering significant potential for industrial adoption.

“The development of this green nanomicelle platform stems from our commitment to merging scientific excellence with environmental responsibility,” said Prof. Indu Pal Kaur. “Our system is highly adaptable, stable, and can encapsulate a wide range of drug molecules, especially those that are poorly soluble in water, improving their bioavailability and therapeutic efficiency.”

Preliminary studies have demonstrated the nanomicelles’ stability, high encapsulation efficiency, and sustained drug release capabilities. These features make the platform suitable for various medical applications, particularly in oncology, infectious diseases, and chronic illness management, where precision and prolonged drug action are critical.

Recognizing the global relevance of the technology, Panjab University has moved swiftly to protect the intellectual property by filing for both Indian and Patent Cooperation Treaty (PCT) international patents. This strategic move ensures the platform’s commercial potential can be leveraged not only in India but across global markets.

“The green nanomicelle platform reflects the university’s vision of fostering innovation that aligns with sustainable development goals,” said a spokesperson from Panjab University’s Innovation and Entrepreneurship Development Centre. “It’s a proud moment that exemplifies how cutting-edge research can contribute to both healthcare advancement and ecological balance.”

The university is now exploring partnerships with pharmaceutical companies for technology transfer, aiming to bring this innovation from the lab to the marketplace. The research team is also working on further pre-clinical validation and is hopeful about future collaborations for clinical translation.

As the global pharmaceutical sector increasingly shifts focus toward green technologies, Panjab University’s contribution through this solvent-free nanocarrier platform is both timely and transformative. It sets a new benchmark in combining scientific ingenuity with sustainable practices, reinforcing India’s role as a leader in eco-conscious health innovation.